FDA inspection insights

MasterControl Inc., provider of innovative quality management software solutions, recently released an article addressing facility inspections. Many medical device firms receive Form 483 citations from the FDA because of issues related to quality audits, corrective and preventive actions, employee training records, and documentation control. In its Q&A article, MasterControl interviews a medical device specialist with the FDA’s Office of Regulatory Affairs (ORA) who has spent the past twelve years inspecting domestic and international medical device companies. The article discusses several important topics, including the twelve most common problems pertaining to quality audit; things that FDA investigators look for in terms of CAPA and training control; and what medical device firms should do to prepare for an FDA inspection. To download a copy, visit www.mastercontrol.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.

Leave a Reply

Your email address will not be published. Required fields are marked *


Introducing Semiconductor Digest
04/30/2019Semiconductor Digest is a new magazine dedicated to the worldwide semiconductor industry...
KLA-Tencor announces new defect inspection systems
07/12/2018KLA-Tencor Corporation announced two new defect inspection products at SEMICON West this week, addressing two key challenges in tool and process monit...
3D-Micromac unveils laser-based high-volume sample preparation solution for semiconductor failure analysis
07/09/2018microPREP 2.0 provides order of magnitude time and cost savings compared to traditional sample...